Agios Pharma shares jump as U.S. FDA expands approval for blood disorder drug

Agios Pharma shares jump as U.S. FDA expands approval for blood disorder drug

Aqvesme is expected to be available late next month, following the implementation of a required safety programme

Leave a Reply

Your email address will not be published. Required fields are marked *